Clinical Trial Update: Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating determinants of mercaptopurine toxicity during maintenance therapy for pediatric acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Mercaptopurine (Mercaptopurine)

Snippet

Sponsor: Shandong University | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: UNKNOWN